J. J. Spinelli | Charles Explorer

Randomized trial of adjuvant equitoxic dose-escalated anthracycline (A)-containing regimen of doxorubicin, cyclophosphamide (AC) versus cyclophosphamide, methotrexate, 5-FU (CMF) for stage 1-2 breast cancer (BrCa): Can equitoxicity compensate for ag

Publication without faculty affiliation